Untitled

Loading Events
Find Webinars

Event Views Navigation

September 2020

“Hypertensive Disorders of Pregnancy”

https://share.vidyard.com/watch/DwyGHLX1cwoyYUCXMEQuNg?   Download a copy of this content. Supporting Documents & Procedures Checklists Please Note: Continuing education credit is only available to those attending the session live. CE credit is not available when accessing the program on demand. HealthTrust presents…“Hypertensive Disorders of Pregnancy” (Part 2 Update in the Maternal Morbidity & Mortality series) Despite a worldwide trend toward improvement in maternal morbidity and mortality, rates in the U.S. have surged in recent years. Specifically, the unacceptable rates of preventable adverse events…

Find out more »

“COVID-19 Webinar Series: Clotting Disorders”

American College of Medical Toxicology * presents…"COVID-19 Webinar Series: Clotting Disorders" In response to the COVID-19 pandemic, ACMT is collaborating with national and international partner societies as well as members of the Global Clinical Toxicology Community to offer periodic web-based presentations, panel discussions, and briefings. Subject-matter experts and practitioners, many of whom are caring for COVID-19 patients, will present on emerging issues related to COVID-19, provide updates on what they are facing in their clinics and hospitals, and participate in…

Find out more »

May 2020

“Blood Shortage & Coagulopathy in the COVID-19 World”

Z-Medica* presents..."Blood Shortage & Coagulopathy in the COVID-19 World" This clinical forum, driven by a diverse panel of trauma surgeons, will focus on the topic of blood shortage and coagulopathy in a COVID-19 world and also other implications and challenges created due to the pandemic. We welcome you to register for the webinar event on May 19, 2020. Presenters: A. Britt Christmas, M.D., FACS  |  Professor of Surgery, Atrium Health   |  Vice Chief & Associate Medical Director of Trauma   |  President…

Find out more »

September 2019

“Stop the Bleed: The Development & Implementation of an Anticoagulation Monitoring & Reversal Protocol”

Cancelled**This event has been cancelled. Our apologies for any inconvenience.** HealthTrust presents..."Stop the Bleed: The Development & Implementation of an Anticoagulation Monitoring & Reversal Protocol" Since the approval of direct oral anticoagulants (DOACs) for the prevention of stroke in patients with non-valvular atrial fibrillation and the prevention and treatment of venous thromboembolism (VTE), research has continued to delineate what other applications DOACs might have. Pharmacists may not be aware of updates to the indications, doses and applications for these medications.…

Find out more »

May 2019

“New Indications & Doses for Direct Oral Anticoagulants (DOACs)”

Download a copy of this content. Access the recording. HealthTrust presents..."New Indications & Doses for Direct Oral Anticoagulants (DOACs) Since the approval of direct oral anticoagulants (DOACs) for the prevention of stroke in patients with non-valvular atrial fibrillation and the prevention and treatment of venous thromboembolism (VTE), research has continued to delineate what other applications DOACs might have. Pharmacists may not be aware of updates to the indications, doses and applications for these medications. Recently, rivaroxaban has received FDA approval…

Find out more »

“Thromboelastography (TEG) & Its Role in Determining a Patient’s Coagulation Status”

Access the recording. Download a copy of this content. HealthTrust presents..."Thromboelastography (TEG) & Its Role in Determining a Patient’s Coagulation Status" With the approval of many more direct oral anticoagulants (DOACs), thromboelastography (TEG) is a test commonly utilized in order to test the efficiency of blood clotting in these patients. TEG offers many benefits, including information regarding fibrin formation, clot strength and fibrinolysis. A TEG analysis provides a bigger picture of a patient’s coagulation status compared to INR or PTT…

Find out more »

“HIT or Miss: Direct Oral Anticoagulants for Heparin-induced Thrombocytopenia”

Access the recording. Download a copy of this content. HealthTrust presents..."HIT or Miss: Direct Oral Anticoagulants for Heparin-induced Thrombocytopenia" Heparin-induced thrombocytopenia (HIT) is a life-threatening complication that may occur after exposure to heparin, resulting in both thrombocytopenia and an increased risk of thrombosis. Management of the acute phase of HIT involves discontinuation of all heparin-containing products and initiation of therapeutic anticoagulation with a parenteral non-heparin anticoagulant. Evidence-based clinical practice guidelines historically supported transitioning from a parenteral anticoagulant to an oral…

Find out more »
+ Export Events